Media Coverage

 

Dear Friends,

We are excited to share with you that Immuneregen Biosciences has been nominated by the Vaccine Industry Excellence Awards as the Best Vaccine Start-up Company.

This nomination adds to all of the great progress we have been making as a company and reconfirms our impact in the industry.

Awards will be given at the World Vaccine Congress in Arlington, VA on April 22, 2008 where our Chief Scientific Officer will have the honor of speaking.

We will continue to update you after the awards are presented; hopefully with news of a win.

Thank you again for your continued support.

Kind regards,

Michael K. Wilhelm

CEO

 

http://www.terrapinn.com/2008/wvcwawards/categories.stm

 

 

General Inquiries:
info@immuneregen.com

Media Coverage:
Amendola Communications
Jan Shulman
Executive Vice President
480.664.8412, ext. 12
JShulman@acmarketingpr.com

Investor Relations:

Tony Schor or Lindsay Kenoe
Investor Awareness, Inc.
847-945-2222
www.investorawareness.com
investors@immuneregen.com

Copyright © 2003-2008, ImmuneRegen Biosciences, Inc. All rights reserved.